SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-21-034421
Filing Date
2021-06-25
Accepted
2021-06-25 09:32:34
Documents
13
Period of Report
2021-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A drrx-8ka_20210615.htm   iXBRL 8-K/A 63325
2 EX-3.1 drrx-ex31_6.htm EX-3.1 12349
  Complete submission text file 0001564590-21-034421.txt   214546

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20210615.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20210615_lab.xml EX-101.LAB 20183
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20210615_pre.xml EX-101.PRE 12065
6 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8ka_20210615_htm.xml XML 4357
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31615 | Film No.: 211044930
SIC: 2834 Pharmaceutical Preparations